Human Immunodeficiency Virus Book



Aka: Tenofovir, Tenofovir Disoproxil, TDF, Tenofovir Alafenamide, TAF, Viread
  1. See Also
    1. Anti-Retroviral Therapy
    2. Nucleoside Reverse Transcriptase Inhibitor
  2. Preparations
    1. Tenofovir Disoproxil Fumarate (TDF)
      1. Original Tenofovir formulation and used in Stribild, Truvada and Complera
      2. Associated with nephrotoxicity and decreased Bone Mineral Density
    2. Tenofovir Alafenamide Fumarate (TAF)
      1. Tenofovir formulation released in 2016 and used in Genvoya, Descovy, Odefsey
      2. TAF appears to have less adverse Renal Function and Bone Mineral Density effects than the original TDF
      3. TAF is associated with greater weight gain and dyslipidemia than TDF
  3. Mechanism
    1. Nucleoside Reverse Transcriptase Inhibitor
  4. Adverse Effects
    1. See nRTI for adverse effects attributed to the class
    2. Renal dysfunction
      1. Increased Serum Creatinine
      2. Proteinuria
      3. Electrolyte abnormalities
        1. Glycosuria
        2. Hypophosphatemia
      4. Acute Renal Failure (1% risk)
        1. Associated with longer duration of therapy, advanced HIV or pre-existing renal disease
    3. Gastrointestinal
      1. Diarrhea
      2. Nausea or Vomiting
      3. Flatulence
    4. Miscellaneous
      1. Headache
      2. Hepatitis B flares on withdrawal of medication
  5. Dosing
    1. Dose: 300 mg orally daily
  6. Monitoring
    1. Obtain Urinalysis every 6 months when on Tenofovir Disoproxil Fumarate
    2. Obtain baseline Renal Function and Phosphorus, then at 2-8 weeks, and then every 3-6 months
  7. References
    1. (2016) Presc Lett 23(9)
    2. (2009) Treat Guidel Med Lett 7(78): 11-22 [PubMed]
    3. Reust (2011) Am Fam Physician 83(12): 1443-51 [PubMed]
Medication Costs
viread (on 3/22/2017 at Medicaid.Gov Pharmacy Drug pricing)
VIREAD 300 MG TABLET $34.28 each
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Tenefovir (C2735014)

Concepts Organic Chemical (T109) , Antibiotic (T195)
LNC MTHU034726
English Tenefovir
Derived from the NIH UMLS (Unified Medical Language System)

You are currently viewing the original '\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree